Collaboration Agreement (New Zealand)

A collaboration agreement in New Zealand is a contract between two or more independent parties who agree to work together on a defined project or initiative, while remaining legally separate entities. Collaboration agreements are used in a wide range of contexts — including research and development (R&D) collaborations between universities and businesses, creative collaborations between artists and production companies, technology partnerships between software companies, and joint bids by contractors on government procurement projects. Under the Contract and Commercial Law Act 2017 (CCLA), a collaboration agreement is a binding commercial contract that creates enforceable rights and obligations between the parties. The agreement must clearly distinguish a collaboration (a limited-purpose contractual partnership with each party contributing resources and sharing outcomes) from a legal partnership under the Partnership Act 1908, which would expose the parties to joint and several liability for each other's acts. The agreement should expressly state that it does not create a partnership or a joint venture with mutual liability.

IP management is typically the most complex and commercially significant aspect of a New Zealand collaboration agreement. The agreement must address three categories of IP: (1) background IP — pre-existing IP owned by each party before the collaboration; (2) foreground IP — new IP created during the collaboration; and (3) sideground IP — IP developed by one party independently during the collaboration but connected to the project. For background IP, each party typically retains ownership and grants the other party a licence to use it for the purposes of the collaboration. For foreground IP, the parties must agree whether it is owned by one party, jointly owned, or held in a new entity. Under New Zealand law, joint ownership of IP can be complex — either owner may exploit jointly-owned copyright or unregistered IP independently without the other's consent (unless the agreement restricts this). For patents under the Patents Act 2013, joint ownership requires joint consent for commercialisation in some circumstances. The agreement should specify the exploitation rights, sub-licensing rights, and commercialisation split for all categories of IP.

For research and academic collaborations in New Zealand, the right to publish results is a key issue. Universities and Crown Research Institutes (CRIs) — such as GNS Science, Manaaki Whenua – Landcare Research, and NIWA — are committed to open publication of research results. Business partners may want to delay or restrict publication to protect commercially sensitive information or to allow time to file patent applications. A collaboration agreement should specify: whether either party has the right to publish results; whether publication must be approved by both parties; the maximum delay that may be imposed on publication to protect commercial interests (typically 30 to 90 days); whether the parties will co-author publications and how authorship will be determined; and how any trade secrets or confidential commercial information will be excluded from publications. Under the Patents Act 2013, public disclosure of an invention before filing a patent application may affect the novelty of the invention and should be avoided. Publication review provisions in collaboration agreements are critical to protect both the commercial interests of the business party and the academic freedom of the research party.

Callaghan Innovation is a New Zealand Crown entity that funds R&D collaborations between businesses and research organisations through co-investment grants, student grants, and project grants. Callaghan Innovation grants are subject to specific terms and conditions that affect collaboration agreements. In particular, Callaghan Innovation requires that: the funded business has a written R&D agreement with any research partner; the IP created with grant funding is retained in New Zealand (or subject to prescribed approval if transferred offshore); the grant is used only for eligible R&D activities as defined in the Callaghan Innovation Act 2012; and financial reporting and milestone reporting obligations are met. If the collaboration is funded by Callaghan Innovation, the collaboration agreement must comply with the grant terms and should address the grant conditions relating to IP ownership, New Zealand commercialisation, and reporting. The agreement should also address the implications of the Research, Science, and Technology Act 2010 for publicly funded research collaborations with universities and CRIs. Tax credits for R&D under the Income Tax Act 2007 may also be available and should be considered.

A Collaboration Agreement (New Zealand) does not legally require a lawyer in New Zealand, and individuals and businesses may draft and execute the document independently. The Companies Act 1993 does not mandate legal representation for the creation or signing of this type of document. However, seeking independent legal advice from a qualified New Zealand lawyer is recommended for transactions involving substantial financial value, complex regulatory requirements, or cross-border elements where multiple legal jurisdictions may apply. A lawyer can verify that the document complies with all applicable statutory requirements, identify potential risks specific to the transaction, and confirm that the terms adequately protect the interests of all parties involved. The High Court of New Zealand has jurisdiction over disputes arising from this type of document, and Companies Office may impose additional compliance obligations depending on the nature of the underlying transaction. Professional legal review is particularly advisable where the document will be submitted to government agencies or used as evidence in legal proceedings.